Core Viewpoint - The company has successfully completed the domestic health food filing for two products, which will enhance its product line and competitiveness in the health food sector, aligning with its strategic plan in the health industry [1] Group 1 - The company's wholly-owned subsidiary, Jinhua Shouxian Valley Pharmaceutical Co., Ltd., has obtained filing certificates for "Shouxian Cloud Broken Ganoderma Spore Powder Tablets" and "Shouxian Red Broken Ganoderma Spore Powder Tablets" [1] - The successful filing of these products is not expected to have a significant impact on the company's recent production and operations [1] - This development will help to further supplement and improve the company's product categories, enriching its product line [1]